News

Get the analytical method for COVID-19 drugs by LC-MS/MS

28.05.2020

Get the analytical method for COVID-19 drugs by LC-MS/MS

Alsachim is proud to share its analytical method to analyze the COVID-19 drugs. This LC-MS/MS application allows to monitor 9 analytes: Favipiravir, GS 441524, Remdesivir, Hydroxychloroquine, D [...]

Alsachim and CIL join forces in the fight against COVID-19

19.05.2020

Alsachim and CIL join forces in the fight against COVID-19

Through a commercial partnership with Cambridge Isotope Labs (CIL), Alsachim is offering American researchers an assortment of unlabeled and stable isotope-labeled antiviral drug standards and [...]

Alsachim joins the fight against COVID-19

31.03.2020

Alsachim joins the fight against COVID-19

Joining the fight against the Coronavirus, Alsachim, one of the world leaders in TDM standards organic synthesis, is supporting healthcare actors to respond the urgency caused by the [...]

New covid-19 research products

02.03.2020

New covid-19 research products

Since the beginning of the year, studies of new potential drugs to defeat the coronavirus have increased. Multiple tests are conducted in a remarkable timeline in order to come up with the most [...]

World Cancer Day: 4 February

04.02.2020

World Cancer Day: 4 February

10 million people die every year from cancer. More than one third of cancer cases can be prevented. Another third can be cured if detected early and treated properly.2020 marks the 20th [...]

New FDA-approved protein kinase inhibitors available

16.12.2019

New FDA-approved protein kinase inhibitors available

Alsachim has developed all the protein kinase standards approved by the FDA, you can now get access to these standards to boost your research. Protein Kinase inhibitors have always been at the [...]

News categories

News archives